Paul Pentel
Affiliations: | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Pharmacology, Pharmacy, Immunology, Public HealthGoogle:
"Paul Pentel"Children
Sign in to add traineeStephanie D. Gozum | grad student | 2006 | UMN |
Samuel A. Roiko | grad student | 2009 | UMN |
Katherine E. Cornish | grad student | 2013 | UMN |
Michael D. Raleigh | grad student | 2013 | UMN |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Crouse B, Miller SM, Muelken P, et al. (2023) A TLR7/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. Npj Vaccines. 8: 107 |
Hamid FA, Marker CL, Raleigh MD, et al. (2022) Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine. 40: 3244-3252 |
Raleigh MD, Beltraminelli N, Fallot S, et al. (2021) Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies. Plos One. 16: e0254247 |
Raleigh MD, King SJ, Saykao AT, et al. (2020) Functional in vivo characteristics of antibodies generated by an oxycodone vaccine The Faseb Journal. 34: 1-1 |
Hu Y, Smith D, Zhao Z, et al. (2019) Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine. Nanomedicine : Nanotechnology, Biology, and Medicine. 102023 |
Zhao Z, Hu Y, Harmon T, et al. (2019) Effect of adjuvant release rate on the immunogenicity of nanoparticle-based vaccines: A case study with a nanoparticle-based nicotine vaccine. Molecular Pharmaceutics |
Baruffaldi F, Raleigh MD, King S, et al. (2019) Formulation and characterization of conjugate vaccines to reduce opioid use disorders suitable for pharmaceutical manufacturing and clinical evaluation. Molecular Pharmaceutics |
Raleigh MD, Baruffaldi F, Peterson SJ, et al. (2018) Vaccination reduces fentanyl distribution to the brain and fentanyl-induced toxicity in mice and rats: a potential role for a prophylactic vaccine against fentanyl-induced overdose. The Journal of Pharmacology and Experimental Therapeutics |
Hu Y, Zhao Z, Harmon T, et al. (2018) Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines. Biomaterials. 182: 72-81 |
Pentel PR, Raleigh MD, LeSage MG, et al. (2018) The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats. Bmc Biotechnology. 18: 46 |